Forty years of research into retinoblastoma has seen wide-ranging changes in our knowledge of the histogenesis of this childhood tumour and in the treatment of the disease. These changes, and some of the more recent developments in the molecular biology of this tumour are 
this period and many of the contemporary con cepts about the disease at that time have become historical footnotes. Although research into the conventional histopathology of the disease con tinues at the Institute, the field has been widened with collaborative studies to include much more emphasis on genetics and molecular biology, as well as investigation of therapies. The mortality rate for retinoblastoma has dropped, from almost 100% (still true in some more deprived countries, where expert ophthalmological and genetic services are lacking)4 in the early 19th century, falling to 95 % in 1867 and 43 % in 1916. 5 By 1948 it was recognised that survival was influenced by site, size, multiplicity, bilaterality and extension of the tumour along the optic nerve, falling dramatically if there was involvement of the cut end of the nerve, orbital extension or metastatic disease.
In countries with good ophthalmic, oncolo gical and radiotherapeutic services, survival is assured for 92 % of children with this disease but some children still die with intracranial exten sion, meningeal disease and haematogeneous spread. 6 The last eight percent4 represents a challenge both in terms of diagnosis, and treat ment; it includes patients, the nature of whose disease would not have been recognised in 19 48.
The most challenging group of patients to treat are those with ectopic intracranial retino blastoma, 'trilateral retinoblastoma'.7 , 8 , 9 , 10 These patients are children, usually with bilateral retinoblastoma, who develop pineal or supra sellar tumours, in the 'third eye'7 often some time after the initial presentation.8 In the past, these intracranial tumours would have been regarded as manifestations of metastatic rather than protean disease. CT scanning and MRI imaging have facilitated discovery of these tumours. Unfortunately, thus far, none of these patients have survived despite chemotherapy,
11
and radiotherapy. Conventional histopathology of the globe has nothing to offer in terms of predicting which patients will develop ectopic intracranial retinoblastoma, but may influence the way some bilaterally or unilaterally affected children are treated. 
